Jonathan Chang, an analyst from Leerink Partners, maintained the Buy rating on Vincerx Pharma Inc (VINC – Research Report). The ...

In Q2, it brought in $11.3 billion in sales, 36% higher than a year prior, and it cranked up its annual revenue guidance for ...

Shares to buy or sell: Rajesh Palviya has recommended to buy, hold, and accumulate Ajanta Pharma Ltd, Tata Chemicals Ltd, and JSW Steel Ltd. Sudarshan Pharma’s shares rose nearly 2% after ...

The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the ...

Vandalia Fire posted on social media that several fire departments responded after an explosion on the roofing of a ...

Italian pharma group Recordati said on Friday it would ... of Pfizer's sickle cell disease treatment Oxbryta. Reuters, the news and media division of Thomson Reuters, is the world’s largest ...

It is a privilege to welcome Erik to the Inozyme Board of Directors at this exciting juncture for Inozyme as we continue to lay the groundwork for our transition into a commercial-stage company,” said ...

An analysis of Q3 layoffs in pharmaceutical and biotech companies shows a decline in numbers as the summer progressed. Read ...

A bill aimed at reining in the outsize power of pharmacy benefit managers made it to the governor’s desk for naught.

Sun Pharmaceutical Industries Ltd. 524715 shares inched up 0.63% to 1,916.85 Indian rupees Tuesday, on what proved to be an all-around great trading session for the stock market, with the BSE SENSEX ...

In 2007, researchers at University of Gothenburg, Sweden published the first in a series of studies showing massive pollution with antibiotics from pharmaceutical factories in India. A new model ...

Check out those stories and more pharmaceutical news highlights from this week. A Brazilian politician is making an interesting campaign pitch: Ozempic for all. Eduardo Paes, the mayor of Rio de ...